temozolomide has been researched along with selenium in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Amin, S; Cheng, Y; Huber-Keener, KJ; Liao, J; Ren, X; Sharma, AK; Sk, UH; Sun, YW; Yang, JM; Zhang, L; Zhang, Y | 1 |
Övey, İS; Özkal, B | 1 |
Berthier, S; Boutonnat, J; Chovelon, B; Faure, P; Garrel, C; Hazane-Puch, F; Larrouquère, L; Paucot, H; Vacchina, V | 1 |
3 other study(ies) available for temozolomide and selenium
Article | Year |
---|---|
Rational incorporation of selenium into temozolomide elicits superior antitumor activity associated with both apoptotic and autophagic cell death.
Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Brain Neoplasms; Calpain; Cell Line, Tumor; Dacarbazine; Glioma; Humans; Male; Melanoma; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Nude; Selenium; Skin Neoplasms; Temozolomide; Xenograft Model Antitumor Assays | 2012 |
Selenium enhances TRPA1 channel-mediated activity of temozolomide in SH-SY5Y neuroblastoma cells.
Topics: Apoptosis; Cell Line, Tumor; Humans; Neuroblastoma; Reactive Oxygen Species; Selenium; Temozolomide; TRPA1 Cation Channel | 2020 |
Preclinical Evaluation of Sodium Selenite in Mice: Toxicological and Tumor Regression Studies after Striatum Implantation of Human Glioblastoma Stem Cells.
Topics: Animals; Apoptosis; Brain Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Corpus Striatum; Glioblastoma; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplastic Stem Cells; Selenium; Sodium Selenite; Temozolomide; Trace Elements; Treatment Outcome; Tumor Burden; Xenograft Model Antitumor Assays | 2021 |